Tenon Medical shares jump 20.07% premarket on updated earnings guidance.

Tenon Medical surged 20.07% in premarket trading following pre-market updates from BioPharmCatalyst highlighting its earnings guidance. The report, included in a pre-market summary, noted Tenon Medical's TNON earnings guidance, positioning the stock as a focal point in biotech sector activity. While the update also referenced Artelo Biosciences’ equity purchase agreement, the direct catalyst for Tenon’s premarket rally was its own earnings-related developments, signaling improved investor sentiment toward its financial outlook.